3.38
-0.25 (-6.89%)
-0.25 (-6.89%)
Upgrade to Real-Time
Afterhours (Closed)
Low
1.00
High
5.98
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Infinity Pharmaceuticals Inc | INFI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.25 | -6.89% | 3.38 | 19:58:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.42 | 3.36 | 3.52 | 3.38 | 3.63 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.35 | 3.45 | 0.10 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,709 | 1,961,120 | $ 3.43 | $ 6,725,098 | - | 1.00 - 5.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:39:57 | 41 | $ 3.35 | USD |
Period:
Draw Mode:
Infinity Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 299.87M | 88.72M | 86.80M | $ 1.72M | $ - | -0.68 | -6.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 466.12k | 3.80% |
Infinity Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INFI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.5838 | 3.63 | 3.20 | 3.45 | 1,831,742 | -0.2038 | -5.69% |
| 1 Month | 3.05 | 3.89 | 3.04 | 3.53 | 2,122,807 | 0.33 | 10.82% |
| 3 Months | 3.05 | 3.89 | 1.48 | 2.69 | 7,794,363 | 0.33 | 10.82% |
| 6 Months | 3.65 | 3.89 | 1.48 | 2.78 | 4,485,968 | -0.27 | -7.4% |
| 1 Year | 1.10 | 5.98 | 1.00 | 3.03 | 3,398,741 | 2.28 | 207.27% |
| 3 Years | 2.33 | 5.98 | 0.60 | 2.78 | 1,319,108 | 1.05 | 45.06% |
| 5 Years | 1.52 | 5.98 | 0.60 | 2.60 | 1,169,841 | 1.86 | 122.37% |
Infinity Pharmaceuticals Description
| Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development. |
